DAFTAR PUSTAKA

Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. 2002.
Molecular Biology of the Cell. Edisi ke-4. Garland Science: New York

Alvarez, UG. 2012. Factors associated with late presentation of HIV and
estimation of antiretroviral treatment need according to CD4 lymphocyte
count in a resource-limited setting: data from an HIV cohort study in india.
Interdiscip Perspect Infect Dis.

Badri M, Lawn SD, Wood R. 2008. Utility of CD4 cell counts for early prediction
of virological failure during antiretroviral therapy in a resourcelimited
setting. BMC infectious diseases [Internet]. Jan [cited 2014 Mar 14];8(1):89.
Available from: http://www.biomedcentral.com/ 14712334/8/89.

Bonnet, F, Thiebaut R, Chene G, Neau D, Pellegrin JL, dan Mercie P. 2005.

Determinants of clinical progression in antiretroviral-naive HIV-infected
patients starting highly active antiretroviral therapy. Aquitaine Cohort,
France. 1996-2002. HIV Med. 6(3):198-205.

Boris, J, Danielle P, Musie G, Carmen C, Marcus A, Henry S, Richard AM, and

Bruce DW. 2012. Factors predicting discordant virological and
immunological responses to antiretroviral therapy in HIV-1 clade C
infected Zulu/Xhosa in South Africa. PLOS ONE 7:31161.

Burnet Indonesia (Mac Farlane Burnet Institute for Medical Research and Public
Health Limited). 2005. Buku Pegangan Konselor HIV, edisi 2. Diunduh dari
www.burnet.internationalhealth.edu.au

Crowe, Suzanne M., dkk. 1991. Predictive value of CD4 lymphocyte numbers for
the develompment of opportunistic infection and malignances in HIV-
infected person, Journal of Acquired Immuno Deficiency Syndrom. 4:770-
776. New York : Raven Press Ltd.

De Maat,Monique, dkk. 2003. Drug interactions between antiretroviral drugs and

comedicated agents. Clinic Pharmacokinetic. 42 (3), 23-262. Aclts
International united.

Departemen Kesehatan Republik Indonesia. 2004. Pedoman Nasional Terapi

Antiretroviral. Jakarta. Departemen Kesehatan Republik Indonesia.

Departemen Kesehatan RI. 2006. Pedoman pelayanan Kefarmasian Untuk Orang

Dengan HIV/AIDS. Jakarta. Departemen Kesehatan Republik Indonesia.

Departemen Kesehatan RI. 2007. Pedoman Nasional Terapi Antiretroviral. Edisi

kedua. Jakarta. Departemen Kesehatan Republik Indonesia.

1
Diego, LC, Kristien V, Larissa O, David I, Juan E, Lynen L, Eduardo G, and
Carlos S. 2008. Predictors of CD4+ cell count response and of adverse
outcome among HIV-infected patients receiving highly active antiretroviral
therapy in a public hospital in Peru. International Journal of Infectious
Diseases 12: 325-331.

Dipiro, J.T. 2005. Pharmacotherapy. A Pathophysiologic approach. Sixth

Edition. USA: McGraw-Hill Companies Inc.

Ditjen PPM&PL Depkes RI. 2009. Statistik kasus HIV di Indonesia, dilaporkan
s/d Desember 2014. Jakarta. Departemen Kesehatan Republik Indonesia.

Dore, Gregory dan Sasadeusz, Joe. 2006. Koinfeksi HIV dan Hepatitis Virus.
Australia. Australasian society for HIV Medicine Inc.

Evan W, Robert SH, Benita Y, Richard H,Michael VOS. 2004. The impact of
adherence on CD4 cell count responses among HIV-infected patients.
Journal of acquired immune deficiency syndromes [Internet]. [cited 2014
Mar 16];35:261–8. Available from:http://journals.lww.com/jaids/
Abstract/2004/03010/The_Impact_of_Adherence_on_CD4_Cell_Count.6.as

Evering MD,Teresa H., & Markowitz Md,Martin. (2008). HIV-1 integrasse

inhibitor. from The PRN notebook. New York. Vol.13. Physicians’Research
Network.

Fletcher, C., Kakuda, T.2002. HIV infection. In: Dipiro, J.T., Talbert, R.L., Yee,
G.C., Matzke, G.R., Wells, B.G., Posey, L.M. (Eds), Pharmacoterapy a
Patophysiological Approach, 5th ed, St Louis: McGraw-hill Companies, Inc,
p. 2151-2171.

Fredy, Felix C, Frans Liwang, Rudy Kurniawan, Anna Uyainah ZN. 2012. The
corelation between CD4+ t-lymphocyte count and tuberculosis form in TB-
HIV coinfected patients in Indonesia. The Indonesian Journal of Internal
Medicine. 44: 122-127.

Bartlet JG, Gallant JT, 2006, Medical Management of HIV Infections, John
Hopkins University School of Medicine, Australia.

Gandhi, RT, John S, Ellen C, David MA, Benigno R, Thomas C.M, Martin SH,
Robert WS, Gregory KR, Richard BP, and the ACTG 384 Team. 2006.
Effect of baseline and treatment-related factors on immunologic recovery
after initiation of antiretroviral therapy in HIV-positive subjects: results
from ACTG 384. Journal of Acquired Immune Deficiency Syndromes
42:426-434.

Garcia, F, Elisa D Lazzari, Montserrat P, Pedro C, Gabriel M, Meritxell N, Emilio

F, Esteban M, Josep M, Jose L Blanco, Jose M Miro, Tomas P, Teresa G,

2
 dan Jose M Gatell. 2000. Long-term CD4+ t-cell response to highly active
antiretroviral therapy according to baseline CD4+ t-cell count. Journal of
Acquired Immune Deficiency Syndromes 36(2) :702-713.

Gayle, HD and GL Hill. 2001. Global Impact Of Human Immunodeficiency Virus

And AIDS. Clinical Epidemiology Reviews. 14 (2): 327-335.

Ghate, MV. 2000. Relationship between clinical conditions and cd4 counts in hiv-
infected persons in Pune, Maharashtra, India. Natl Med J India. Jul-
Aug;13(4):183-7.

Greenbaum, Adena H., dkk. 2008. Effect of age and HAART Regimen on clinical
respon in an Urban cohort of HIV infected individual. AIDS NIH Public
Access Author Manuscript. 12:22 (17).

Guatellli, J.C., Siliciano, R.F., Kuritzkes, D.R., Richman, D.D., 2002. HIV.
In:Richman, D.D., Whitley, R.J., Hayden, F.G. (Eds), Clinical Virology, 2nd
ed, Washinton: ASM PRESS, P.685-703.

Hoffmann, C., Rockstroh, J.K., Kamps B. S., 2006. HIV Medicine 2006, Paris:
Flying Publiser

Hoy, Jenifer, Sharon Lewin, Jeffrey JP, Alan Street. 2009. Managing The Patient
On Antiretroviral Therapy. In: Vujovic, O. and Anna P HIV Management in
Australia a Guide For Clinical Care. ed. Australia: Australasian Society for
HIV Medicine Inc, pp. 93-101.

Hughes R., Sabin C. dan Steem J. 2007. Long-term trend in CD4 count in patients
HAART: UK-CHIC Study. Madrid 11th European AIDS Conference.

Hutton B, Mills E, Angel J, Cooper C. Angel J. 2006. CD4 T lymphocyte

recovery with antiretroviral therapy in HIV-HCV coinfection. JAC 62:7329.

Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, et al. 2009.

Impact of hepatitis B virus infection on human immunodeficiency virus
response to antiretroviral therapy in Nigeria. Clinical Infectious Diseases :
an official publication of the Infectious Diseases Society of America

Jawetz, Melnick dan Adelberg. 2008. Medical Microbiology. Twenty Third

Edition. USA: Mc. Graw-Hill Companies Inc.

Judarwanto, Widodo. 2009. Faktor Resiko Gangguan Perkembangan Bicara dan

Bahasa pada Anak

Kassa, Desta, Leonie Ran, Wudneh Weldemeskel, Mekashaw Tebeje, Amelewerk

Alemu, Yodit Alemayehu, et al. 2012. Clinical, hemato-immunological
characteristics of mycobacterium tuberculosis patients with and without

3
 HIV-1 infection: responses to six month tuberculosis treatment. Biomedicine
International 3: 22-33.

Katzung, Bertram G. 2001. Basic and Clinical Pharmacology. Eight Edition.

USA : Mc. Graw-Hill Companies Inc

Kaufmann, GR, Hansjakob F, Bruno L, Luc P, Milos O, Pietro V, et al. 2005.

Characteristics, determinants, and clinical relevance of CD4 t cell recovery
to >500 cells/ml in HIV type 1-infected individuals receiving potent
antiretroviral therapy. Clinical Infectious Diseases (CID) 41: 361–372.

Kementrian Kesehatan RI. 2013. Statistik Kasus HIV/AIDS di Indonesia

Dilapors/d Desember2013. Direktorat Jenderal Pengendalian Penyakit Dan
Penyehatan Lingkungan. Jakarta.

Kementerian Kesehatan RI. 2012. Petunjuk teknis tata laksana klinis ko-infeksi
TB-HIV. Direktorat Jenderal Pengendalian Penyakit Dan Penyehatan
Lingkungan. Jakarta.

Kementrian Kesehatan RI. 2011. Pedoman Nasional Tatalaksana Klinis dan

Infeksi HIV dan Terapi Antiretoviral Pada Orang Dewasa. Direktorat
Jenderal Pengendalian Penyakit Dan Penyehatan Lingkungan. Jakarta.

Laksana Agung Saprasetya Dwi dan Diyah Woro Dwi Lestari. 2010. Faktor-
faktor risiko penularan HIV/AIDS pada laki-laki dengan orientasi seks
heteroseksual dan homoseksual di Purwokerto. Mandala of Health.Volume
4, Nomor 2: 133-123.

Lee, Anne. 2006. Adverse Drug Reaction. 2th Ed. Great Britain : Pharmaceutical
Press. p.342.

Liu, H, H. Yang, X Li, N Wang, H Liu, B.Wang, et al. 2005. Men who have sex
with men and human immunodeficiency virus/sexually transmitted disease
control in China. Cell Res 15 (11-12): 858–864.

Mansjoer, A. 2001. Kapita selekta kedokteran. Edisi 3 Jakarta. Fakultas

Kedokteran Universitas Indonesia. Jakarta.

Mariam, S. 2010. Perbandingan respon imunologi empat kombinasi antiretroviral

berdasarkan kenaikan jumlah CD4 di Rumah Sakit dr. H.Marzoeki Mahdi
Bogor periode maret 2006-maret 2010. Universitas Indonesia. Jakarta.

Mc Evoy, Gerald K. 2004. AHFS Drug Information. Amer Soc Health-System

Pharmacists.

Minzi,OMS. 2009. HIV patients presenting common adverse drug event caused
by Highly Active Antiretroviral Therapy(HAART) in Tanzania. Tanzania
Journal of Health Research. 11:1

4
Mulcahy, Stephen, 2005. The Toxicology of Cigarette Smoke and Environmental
Tobacco Smoke. New York : Biochemical Toxicology

Muzah, BP, S Takuva, M Maskew, and S Delany-Moretlwe. 2012. Risk factors

for discordant immune response among HIV-infected patients initiating
antiretroviral therapy: a retrospective cohort study. Southern African
Journal of HIV Medicine 13(4).

Nurbani, F. 2009. Dukungan sosial pada ODHA. Universitas Gunadarma. Jakarta.

Nursalam. 2007. Asuhan keperawatan pada pasien terinfeksi HIV. Penerbit

Salemba Medika. Jakarta.

Nursalam. 2009. Model holistik berdasar teori adaptasi (roy dan pni) sebagai
upaya modulasi respons imun (aplikasi pada pasien HIV & AIDS).
Universitas Airlangga.

Price, Sylvia A. & Wilson Lorraine M. 2008. Phathophysiology. Clinical

Concepts of Disease processes. four edition. Mrsby Year Book. Inc.

Raffi F Antiretroviral therapy -- new strategies or new drugs? 14th European

AIDS Conference, Brussels, plenary PL6, 2013.

Rahmadini, Yuliani. 2006. Perbandingan kenaikan jumlah CD4 rata-rata

beberapa kombinasi antiretroviral pada pasien HIV/AIDS. Analisis data
rekam medik RS kanker Darmais Jakarta. Depok : Farmasi UI.

Radji, M. 2010. Imunologi dan virologi. PT. ISFI Penerbitan. Jakarta.

Rasmun. 2004. Stres, koping, dan adaptasi. Jakarta: Agung Seto.

Read, Jenifer S. dan Committe on Pediatric AIDS. 2007. Pediatrics. Diagnosis of

HIV-infected in children younger than 18 month in the United State. USA:
American Academy of Pediatrics.

Richman DD. dkk. 1987, Juli 23. The toxicity of azidothymidine (AZT) in the
treatment of patient with AIDS and AIDS-related complex. Nederland
English Journal Medicine. 317 (4), 192

Robbins GK., Daniels B. dan Zheng H. 2000. Predictors of Antiretroviral

Treatment Failure in an Urban HIV Clinic. J.Acquir. Immune.
Defic.Syndrom. 44(1). 30-37.

Smith CJ, Caroline A Sabin, Mike S Youle, Sabine K, Fiona C Lampe, S Madge,
et al. 2004. Factors influencing increases in CD4 cell counts of HIVpositive
persons receiving long-term highly active antiretroviral therapy. The
Journal of Infectious Diseases 190: 1860- 1868.

5
Stockley, I.H. 2008. Stockley’s Drug Interaction. Edisi kedelapan. Great Britain
Pharmaceutical Press.

Tsibris MD, Athe. 2007. Update on CCR5 inhibitor: Scientific rationale clinical
evidence and anticipated uses. New York: from The PRN notebook.Vol.12.
Physicians’Research Network.

UNAIDS. 2013. Case Report United Nations Programme on HIV/AIDS.

Available from: http://www.unaids.org. 12 Februari 2014. (19:00).

Van Lelyveld SFL, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AMJ, et

al. 2012. Long-term complications in patients with poor immunological
recovery despite virological successful HAART in Dutch Athena cohort.
AIDS London, England [Internet]. [cited 2013 Oct 2];26(4):465–74.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22112603.

Viard, JP, Amanda M, Antonio C, Ole K, Birgit R, George P, Norbert V. 2001.

Influence of age on CD4 cell recovery in human immunodeficiency virus–
infected patients receiving highly active antiretroviral therapy: evidence
from the EuroSIDA study. The Journal of Infectious Diseases 183:1290–
4:1290-1294.

WHO. 2004. Division of aids table for grading the severity of adult and pediatric
adverse events 2004; clarification august 2009.Version 1.0. Available from
:http://rsc.techres.com/Document/safetyandpharmacovigilance/Table_for
Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf.

WHO. 2008. Guideline Antiretroviral Therapy For Hiv Infection In Adults And
Adolescents. WHO.

WHO. 2009. Rapid advice: Antiretroviral therapy for HIV infection in adults and
adolescents

WHO. 2010. Antiretroviral therapy for HIV infection in adults and adolescents
Recommendations for a public health approach 2010 revision. Available
from: http://www.who.int/hiv/pub/arv/adult2010/en/. 13 Mei 2014 (17:00).

WHO. 2014 Supplement Guidelines On The Use Of Antiretroviral Drugs For

Treating And Preventing HIV Infection.

Wibowo, Candra. 2002. Penatalaksanaan Baku Dan Menyeluruh Pada

HIV/AIDS. dalam Cermin Dunia Kedokteran. No. 135 tahun 2002.

Wolbers, M, Munuel B, Bernard H, Hansjakob F, Matthias C, Barbara H et al.

2007. CD4+ t-cell increase in HIV-1 infected patient with suppressed viral
load within 1 year after start of antiretroviral therapy. International Media
Press 1359-6535(12): 889-897.